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Abstract.  In this study we have examined the in- 
fluence of perturbation of endothelial cells on the 
amounts of fibronectin and von Willebrand factor in 
their extracellular matrix and the consequences of a 
changed composition of the matrix on platelet adhe- 
sion. For this purpose,  we have used an in vitro perfu- 
sion system with which we can investigate the interac- 
tions of platelets in flowing blood with cultured 
endothelial cells and their extracellular matrix (Sakari- 
assen, K. S., P.  A.  M.  M.  Aarts, P.  G. de Groot, 
W.  P.  M. Houdgk, and J.  J.  Sixma,  1983, J.  Lab.  Clin 
Med.  102:522-535).  Treatment of endothelial cells 
with 0.1-1.0  U/ml thrombin for 2  h  increased the reac- 
tivity of the extracellular matrix, isolated after the 
thrombin treatment, towards platelets by ,o50%.  The 
increased reactivity did not depend on de novo protein 
synthesis but was inhibited by 3-deazaadenosine, an 
inhibitor of phospholipid methylation, which also in- 
hibits the stimulus-induced instantaneous release of 
von Willebrand factor from endothelial cells.  However, 
no changes in the amounts of von Willebrand factor 
and fibronectin in the matrix were detected. Thrombin 
may change the organization of the matrix proteins, 
not the composition. 
When endothelial cells were perturbed with the 
phorbol ester PMA or thrombin for 3 d, the adhesion 
of platelets to the extracellular matrix of treated cells 
was strongly impaired.  This impairment coincided 
with a decrease in the amounts of von Willebrand fac- 
tor and fibronectin present in the matrix. These results 
indicate that, after perturbation, endothelial cells 
regulate the composition of their matrix, and that this 
regulation has consequences for the adhesion of 
platelets. 
I 
N the normal situation, the endothelial cell lining of the 
vessel  wall prevents platelet deposition.  When endo- 
thelial cells are damaged, the subendothelium becomes 
exposed to the blood flow, resulting in adherence of platelets 
to the injured site (27, 35).  Cultured endothelial cells have 
been shown to retain their in vivo polarity. The luminal cell 
surface, exposed to flowing blood, has kept its nonthrom- 
bogenic properties (33).  In contrast, a highly thrombogenic 
extracellular matrix on the abluminal surface,  which can 
support platelet adhesion almost independently of plasma 
factors, is synthesized (10, 34). The extracellular matrix pro- 
duced by cultured endothelial cells has been shown to con- 
tain yon Willebrand factor (14), fibronectin (13), thrombo- 
spondin (21), laminin (6), nidogen (4), collagen types III, IV, 
V  and VIII, (20,  28-30),  and proteoglycans (7).  Both von 
Willebrand factor and fibronectin present in the subendo- 
thelium play an important role in the interaction of platelets 
with this extracellular matrix (10). 
The process of vascular subendothelial biosynthesis, as- 
sembly, and the regulation of its formation is difficult to 
study in vivo, and, consequently, is poorly understood. The 
availability of cultured vessel wall cells that maintain their 
differentiated functions may be helpful in studying the for- 
mation of their extracellular matrix and the role of the differ- 
ent components of the matrix in the adhesion of platelets. 
The study of the interaction of platelets with cultured vessel 
wall cells requires the use of a well-defined flow system that 
mimicks the in vivo flow pattern (43). Recently we have con- 
structed a perfusion chamber that enables us to investigate 
the adhesion of platelets in flowing blood with cultured ves- 
sel wall cells, and their extracellular matrices (33). In the pres- 
ent study we used this perfusion chamber to examine the 
effects of perturbation of endothelial cells on the reactivity 
of the extracellular matrix produced by these cells towards 
platelets. Upon stimulation of endothelial cells with throm- 
bin or the phorbol ester 4[3-phorbol  12-myristate  B-acetate 
(PMA), the extracellular matrix isolated 2 h after stimula- 
tion showed a markedly increased reactivity towards plate- 
lets.  This enhanced deposition of platelets is not due to in- 
creased  amounts of von Willebrand  factor or  fibronectin 
present in the extracellular matrix, nor to a direct proteolytic 
effect of thrombin on the matrix. 
When endothelial cells were exposed to PMA or thrombin 
and the extracellular matrix was isolated 3 d later, the adhe- 
sion of platelets to this matrix was strongly impaired. This 
impairment coincided with a decrease in the amount of yon 
Willebrand factor present in the matrix. These results indi- 
cate that endothelial cells can rapidly reorganize the struc- 
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platelets. 
Materials and Methods 
Cell Culture 
Human vascular endothelial cells were isolated from umbilical veins and 
cultured according to the method originally described by Jaffe et al.  (12) 
with some minor modifications (44). The cells were identified by their typi- 
cal characteristics (12). For the experiments described in this paper, endo- 
thelial cells of the second passage were subeultured on gelatin-coated 25- 
cm  2 culture flasks or on gelatin-coated glass coverslips. Before seeding the 
cells, the gelatin on the glass coverslips was fixated with 0.5% glutaralde- 
hyde. To isolate the extracellnlar matrix, endothelial cells grown to con- 
fluence were exposed to 0.1  M  NI~OH for 30 rain at room temperature 
with gentle shaking. The cell layer was completely removed by this proce- 
dure (33). This isolated extracellular matrix was washed three times with 
PBS (10 mM sodium phosphate, pH 7.4, and 150 mM NaC1) and either used 
the same day for perfasion experiments or extracted with 6 M urea and 1% 
Triton X-100 in PBS for analysis of the yon Willebrand factor or fibronectin 
contents (22). 
Assays 
Von Willebra'nd  factor antigen was determined by an enzyme-linked im- 
munosorbent assay (ELISA). Pooled normal plasma containing 10 Ixg.ml  -~ 
yon Willebrand factor was used as standard. Rabbit polyclonal antibodies, 
monospecific  for yon Willebrand factor, served as solid phase, and a mixture 
of the murine monoclonal antibodies CLB-RAg 35 and CLB-RAg 50 (37) 
were used as an indicator, in combination with peroxidase-labeled sheep 
anti-mouse IgG (Institute Pasteur, Marnes-la-Garenne, France).  The re- 
sponse of serial dilutions of extracellular matrix samples paralleled that of 
purified yon Willebrand factor.  Dissolving yon Willebrand factor in extrac- 
tion buffer followed by dialysis did not alter the results found in the ELISA. 
Fibronectin was measured by an ELISA. Rabbit polyclonal antibodies 
against fibronectin were used as  solid phase and  monoclonal antibody 
against fibronectin CLB-HEC-FN-140 functioned as indicator antibody in 
conjugation with peroxidase-labeled sheep anti-mouse IgG (Institute Pas- 
teur) (25). Fibronectin purified from human plasma, as described below, 
served as standard. The response of serial dilutions of extracellular matrix 
samples paralleled that of  purified plasma fibronectin  dissolved in extraction 
buffer. 
In some experiments an alternative ELISA was used. The extraceUular 
matrix of endothelial ceils cultured in microtiter plates was used as solid 
phase, and the amount of von Willebrand factor and fibronectin was deter- 
mined  with  monoclonal  antibodies  against  von  Willebrand  factor  and 
fibronectin,  respectively,  in  conjugation  with  peroxidase-labeled sheep 
anti-mouse IgG. 
Perfusion Studies 
Perfusions with steady flow (32) were carried out with a rectangular perfu- 
sion chamber (33).  This perfusion chamber can contain glass coverslips 
coated with extracellular matrix. Blood from normal human donors, anti- 
coagulated with  1:10 vol  110 mM trisodiumcitrate, was directly used as 
whole blood in the perfusion system. Perfusions were also performed with 
washed platelets resuspended in a human albumin solution (HAS). In that 
case, platelets were frst isolated and washed as described previously (31). 
The washed platelets were resuspended in HAS: 4 % wt/vol human albumin 
(Behringwerke A.G., Marburg, Federal Republic of Germany) in Krebs- 
Ringer  buffer (4  mM  KCI,  107  mM  NaCI,  20  mM  NaHCOa,  2  mM 
Na2SO4; pH 7.35)  containing 19 mM citrate, 2.5  mM CaCI2 and 5 mM 
glucose (31). To this suspension, washed and packed red cells were added 
to a hematocrit of 0.4. 
After the coverslips with extracellular matrix had been inserted into the 
perfusion chamber, they were rinsed with 25 ml warmed 10-mM Hepes- 
buffered saline, pH 7.4.  The perfusate was prewarmed for 5 min at 37°C. 
This perfusate was recirculated through the perfusion chamber for 5 min 
under nonpulsatile steady flow at a wall shear rate of 1,300/s. The coverslips 
were washed with Hepes-saline and fixed with 0.5% glutaraldehyde as pre- 
viously described (31). After fixation, the coverslips covered with platelets 
1. Abbreviation used in this paper:  HAS, human albumin solution. 
were stained with May-Griinwald-Giemsa. Platelet adhesion was expressed 
as percentage of the surface covered with platelets. This was evaluated by 
en face light microscopy at  1,000x  magnification. The light microscope 
was interfaced with an image analyzer (Quantimet 720;  Imanco, Royston, 
United Kingdom). For every coverslip, 30 fields, each consisting of 500,000 
image points (0.028 mm  2) were selected at random and evaluated. In recent 
studies we have found a good correlation between  the percentage of  adherent 
platelets covering the surface as determined by morphometry, and the num- 
ber of deposited platelets as found by measuring the amount of radiolabeled 
platelets (33). 
Purifications 
Von Willebrand factor was isolated from fresh cryoprecipitates by agarose 
gel filtration on Sepharose CL-4B (Pharmacia, Uppsala, Sweden) as previ- 
ously described (39). The von Willebrand factor in the void volume fraction 
was  farther  purified  by  passing  it  over  a  gelatin-Sepharose column, 
equilibrated with 0.005  M  Tris-HCl (pH 7.4).  Von Willebrand factor was 
precipitated by dialysis against 1.6 M ammonium sulfate, pH 7.0, at 4°C for 
18 h and stored as ammonium sulphate suspension at 4°C until use. The 
purified von Willebrand factor preparation (ristocetin cofactor activity 167 
U/mg per protein) contained no detectable fibronectin and <1% fibrinogen. 
Fibronectin was isolated from normal human plasma by affinity chroma- 
tography  on gelatin-Sepharose (5).  Plasma  was passed over the gela- 
tin-Sepharose column, which was equilibrated with 0.05 M Tris-HCl, pH 
7.4. The column was washed with 1 M NaC1 in 0.05 Tris-HCl, pH 7.4, fol- 
lowed by 1 M urea in the same buffer. Fibronectin was eluted with 6 M urea, 
0.1 M citric acid, pH 4.7 (15). The buffers contained 0.1 M phenylmethylsul- 
phonyl fluoride, 1 mM benzamidine, 5 mM e-aminocaproic acid,  10 mM 
EDTA, and 0.02 % wt/vol sodium azide. The pooled fractions were dialyzed 
at 4°C against Krebs-Ringer buffer,  pH 7.4,  supplemented with  19 mM 
trisodium citrate and 2.5  mM CaCI2.  The fibronectin was stored at 4°C 
and used for experiments within 2 wk. 
Imraunoprecipitation and Gel Electrophoresis 
Endothelial  cells  were  maintained  in  a  medium  with  [35S]methionine 
(Amersham International, Amersham, United Kingdom) for 2 d. The extra- 
cellular matrix was extracted as described above. The ureum/Triton X-100 
extracts were extensively dialyzed against 15 mM imidazole-HCl, pH 7.0, 
140 mM NaCI, 0.1% NP-40, 10 mM benzamidine, 5 mM EDTA.  The dia- 
lyzed extract was precleared with Sepharose-CLB-CAg-ll7 (CAg-U7  is a 
monoclonal antibody against factor VIII).  Fibronectin was first absorbed 
with Sepharose-CLB-HEC-FN-140 (HEC-FN-140 is a monoclonal antibody 
against fibronectin) and then with Sepharose-gelatin. Finally,  the extracts 
were incubated with Sepharose-CLB-RAg-20 (RAg-20 is a monoclonal an- 
tibody against yon Willebrand factor) to absorb von Willebrand factor. Pro- 
teins absorbed to the antifibronectin and anti-von Willebrand factor Sepha- 
roses were eluted with electrophoresis sample buffer (including 2 % sodium 
dodecylsulfate and 0.016% 13-mercaptoethanol),  electrophoretically sepa- 
rated on 6% polyacrylamide gels and visualized by autoradiography. 
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Figure 1.  Effect of thrombin-treatment of endothelial cells on the 
ability of their matrix to support platelet adhesion. Endothelial cells 
were treated with  1 U/ml thrombin during the periods indicated. 
Then  their  matrix  was  isolated  and  perfused  with  whole  blood 
for 5 min at a shear rate of 1,300/s. After fixation of the platelet-cov- 
ered matrices, the percentage of surface coverage was determined 
morphologically.  Results are expressed as mean  +  SD (n  =  4). 
**  P  <  0.005,  *  P  <  0.01  (Peritz' F  test). 
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Statistical analysis was performed according to the Peritz' F  test. 
Materials 
All culture plastics were obtained from Nunc (Roskilde, Denmark); the 
other tissue culture supplies (media, antibiotics, and trypsin) were pur- 
chased from Gibco Biocult (Paisley,  Scotland). Thrombin (human, 3,000 
U/mg protein) and PMA were from Sigma Chemical Co. (St. Louis, MO). 
lonophore  A23187 was  obtained  from  Boehringer  Mannheim  GmbH, 
Mannheim, Federal Republic of Germany. Gelatin and glutaraldehyde were 
from E. Merck (Darmstadt, Federal Republic of Germany). All the other 
chemicals obtained from commercial sources were of the highest purity 
grade available.  Immunoreagents were from the central labot~tory of the 
Netherlands Red Cross Blood Transfusion Service (Amsterdam, The Neth- 
erlands) unless otherwise stated. 
Results 
Short-term Effects of Thrombin on Platelet Adhesion 
to Endothelial Matrices 
Endothelial cells grown to confluence on gelatin-coated glass 
coverslips were incubated with 1 U/ml thrombin for increas- 
ing time periods. The extraceUular matrices of the cells was 
then isolated and the matrices were exposed to flowing blood 
to measure its reactivity towards platelets (Fig.  1). Thrombin 
treatment of the cells resulted in an increased platelet cover- 
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Figure 2. Comparison of the effects  of  thrombin on endothelial cells 
and endothelial cell matrix. Either endothelial cells were treated 
with thrombin (1 U/ml) after which their matrix was isolated (open 
circle) or extracellular matrices were isolated and subsequently in- 
cubated with thrombin (solid circle). After extensive washing with 
a buffer containing 100 ~tg/ml soybean trypsin inhibitor, the ma- 
trices were perfused for 5 min with whole blood (plasma) or plate- 
lets resuspended in HAS. After fixation the percentage of the sur- 
face covered with platelets was determined morphologically. Results 
are expressed is mean +  SD (n  =  4). ** P < 0.005, * P < 0.01 
(Peritz'  F test). 
age of their extracellular matrix. The increase in platelet ad- 
herence to the matrix depended upon the time period for 
which the cells had been exposed to thrombin. After a 2-h 
incubation of the cells with thrombin a maximum in reactiv- 
ity of the extracellular matrix was reached. Compared with 
the matrix of control ceils,  '~50% more platelets adhered. 
Prolonged incubation resulted in a steady decrease of  platelet 
adherence and after 6 h of treatment, platelet coverage of the 
matrix had returned to values obtained with the matrices of 
untreated cells. 
To investigate  if thrombin had a direct proteolytic effect on 
the matrix or if thrombin stimulated the endothelial cells to 
change the composition of their extracellular matrix, the in- 
fluence of thrombin on endothelial cells and endothelial cell 
matrix was compared. For this purpose, part of the cultures 
were treated for indicated periods with thrombin and then the 
extracellular matrices were isolated.  The extracellular ma- 
trices from other cultures were isolated,  and then exposed 
to thrombin. Both types of matrices were exposed to whole 
blood or platelets  resuspended  in  HAS at a  shear rate of 
1,300/s (Fig. 2). Pretreatment of endothelial  cells with throm- 
bin showed a significant increase in the number of platelets 
adhering to the matrix when the matrix were perfused with 
whole blood as well as with platelets  resuspended in HAS. 
When the  extracellular  matrix  was  first isolated  and then 
incubated with thrombin,  no influence (HAS) or decrease 
(whole blood) in the number of platelets adhering to the ma- 
trix was found. When the matrix of  thrombin-treated cells was 
perfused with platelets  resuspended in HAS instead of plas- 
ma, the increase in platelet adherence started earlier but the 
maximal increase reached similar values.  Fig.  3 shows the 
reactivity of the matrix of endothelial cells towards platelets 
when the endothelial cells were treated with different con- 
centrations of thrombin. 0.1  U/ml thrombin already caused 
a significant increase in platelets adhering to the matrix.  A 
maximum increase was reached with 0.5  U/ml thrombin. 
Platelet adhesion to matrices of cultured endothelial cells 
in the absence of plasma factors has an absolute requirement 
for the presence of fibronectin and von Willebrand factor in 
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Figure 3. Dose-response curve of the effect of thrombin. Confluent 
cultures of endothelial cells were incubated with different concen- 
trations of thrombin for 2 h. Then the matrix was isolated and ex- 
posed to platelets resuspended in HAS (5 min, 1,300/s). After fixa- 
tion the amount of platelets adhered to the matrix was determined 
morphometrically. Results are expressed as mean + SD of three to 
five different perfusion experiments. 
de Groot et al.  Platelet Adhesion  to Endothelial  Cell Matrix  699 Table L Effect of Stimuli on the Amount of von Willebrand 
Factor and Fibronectin Present in the Extracellular  Matrix 
Extracellular matrix 
Addition  von Willebrand factor  Fibronectin 
ng/lO  6 cells  ltg/lO  6 cells 
No  addition  108  4-  10  3.7  4-  0.8 
+  Thrombin  (1  U/ml)  97  4-  11  4.4  4-  0.4 
+ A23187 (10 ixM)  95  4-  18  5.7  4-  1.0 
+ PMA (20 ng/ml)  lll  +  21  3.9  4- 0.2 
Confluent cultures of endothelial cells were incubated for 2  h  as indicated in 
serum-free medium. After removal of the cells, the matrix was scraped off the 
flasks in the presence of 6  M  urea and 1% Triton X-100.  After dialysis, the 
amounts of yon Willebrand factor and fibronectin were determined. Results are 
expressed as mean +  SD (n  =  3). Analysis of these results with the Peritz' F 
test showed no significant differences. 
the matrix. Therefore, we measured the amounts of von Wil- 
lebrand  factor and  fibronectin present  in the matrix after 
treatment of the cells with thrombin for 2 h (Table I). After 
thrombin treatment, no significant alteration of the amounts 
of von Willebrand factor and fibronectin in the matrix were 
found. To confirm these results, the relative amount of von 
Willebrand factor and fibronectin in the extracellular matrix 
was measured in an alternative way. Endothelial cells were 
cultured in microtiter plates and after confluence the cells 
were stimulated for 2 h  with PMA or thrombin. Then the 
cells were washed away with ammonia and the exposed ma- 
trix was used as a  solid phase for an ELISA. The relative 
amount of yon Willebrand factor and fibronectin, compared 
with  control  ceils,  was determined with monoclonal anti- 
body CLB-RAg 35 directed against the platelet-binding site 
of von Willebrand  factor (37)  and a  monoclonal antibody 
against  fibronectin,  respectively.  No  differences  between 
stimulated  cells  and  control  cells  could  be detected  (not 
shown). 
To investigate the role of von Willebrand factor in the in- 
crease  in  platelet adherence,  we  preincubated  the  matrix 
with a murine monoclonal antibody, CLB-RAg 35, which in- 
hibits  platelet  adhesion  to  subendothelium  completely by 
blocking the platelet-binding domain on von Willebrand fac- 
tor  (37).  Preincubation  of thrombin-treated matrices  with 
CLB-RAg 35 completely abolished platelet adhesion when 
perfusions  were  performed  with  platelets  resuspended  in 
HAS (Table II). 
In endothelial cells, thrombin stimulates the methylation 
of phosphatidylethanolamine  to  form phosphatidylcholine 
(3).  This process has been found to induce  a  CaZ+-influx, 
and,  due to this  increase  of cytosolic Ca2+-concentration, 
Table II. Effect of  Preincubation  of the Extracellular  Matrix 
with Monoclonal Antibodies against von Willebrand Factor 
Surface coverage 
Addition  Control ascites  CLB.RAg 35 
No  addition  22.8  4-  2.4  1.1  4-  0.2 
+  Thrombin  31.8  4-  3.5  1.9  4-  0.9 
Confluent cultures of endothelial cells were incubated for 2 h as indicated. Af- 
ter removal of the cells, the matrices were incubated for 1 h at room tempera- 
ture with the  indicated monoclonal antibodies.  Subsequent perfusions were 
performed  with platelets resuspended in HAS  for  5  min at a  shear  rate of 
1300/s.  Values are mean  5:  SD,  n  =  3. 
Table IlL Effect of Metabolic Inhibitors on 
Thrombin-stimulated  Increase of the Reactivity of the 
ExtraceUular Matrix 
Surface coverage 
Addition  Mean  +  SD (n  =  4) 
No  addition 
+  Thrombin  (1  U/ml) 
+  3-Deazaadenosine  (10  ~tM) 
+  Thrombin  +  3-deazaadenosine 
+ Thrombin + cycloheximide (10 Ixg/ml) 
+von Willebrand factor (2 Ixg/ml) 
% 
19.4  4-  1.7 
29.7  4-  0.8* 
21.4  4-  0.7 
20.2  4-  2.8 
30.4  +  4.5* 
21.2  +  4.2 
Endothelial cells grown to confluence on coverslips were incubated for 2 h with 
serum-free medium supplemented as indicated. Then the matrix was isolated 
and exposed to platelets resuspended in HAS.  After perfusion the matrices 
were fixed and stained, and the percentage surface coverage was determined 
by morphological evaluation. Results are expressed as mean  +  SD (n  =  4). 
* P  <  0.005 compared with control incubation (Peritz' F  test). 
the release of a storage pool of von Willebrand factor is trig- 
gered (17, 41). Phospholipid methylation and von Willebrand 
factor release can be blocked by 3-deazaadenosine. 3-Deaza- 
adenosine also blocked the increase of reactivity of the extra- 
cellular matrix towards platelets after treatment of the cells 
with thrombin (Table HI). On the other hand, cycloheximide, 
an inhibitor of protein synthesis, was not able to inhibit the 
increase in reactivity of the matrix. When endothelial cells 
were incubated with purified von Willebrand  factor in the 
culture medium for 2 h, no increase in reactivity of the extra- 
cellular matrix could be found (Table III). 
Besides  thrombin,  the  Ca2+-ionophore  A23187  and  the 
phorbol ester PMA can instantaneously induce the release of 
von Willebrand factor from intracellular storage pools. 2-h 
treatment of endothelial cells with 10 [tM A23187 or 20 ng/ml 
PMA also increased the reactivity of the extracellular matrix 
towards platelets (Table IV). 
Long-term Effects of PMA and Thrombin 
on Endothelial Cell Matrices 
Incubation of endothelial  cells with  PMA  impairs the ac- 
cumulation of fibronectin in the culture medium after 2 d, 
whereas the accumulation of von Willebrand factor increases 
under these conditions (25). On the contrary, prolonged in- 
cubation with PMA or thrombin resulted in a severe decrease 
in the amounts of von Willebrand factor and fibronectin pres- 
ent in the endothelial cell matrix after 3 d as quantified by 
ELISA (Table V). The decreases in extracellular matrix con- 
Table IV. Effect of Different Stimuli on the Reactivity  of the 
Extracellular  Matrix towards Platelets 
Addition  Surface coverage 
% 
No  addition  19.4  4-  1.7 
+  Thrombin  (1  U/ml)  29.7  4-  0.8* 
+  A23187  (10  IxM)  29.3  4-  1.1" 
+  PMA  (20 ng/ml)  26.7  4-  1.9. 
Endothelial cells grown to confluence on glass coverslips were incubated for 
2 h with serum-free medium as indicated. The matrices were isolated and ex- 
posed to platelets resuspended  in HAS.  After perfusion,  the matrices were 
fixed and stained, and the percentage surface coverage was determined by mor- 
phological evaluation. Results are expressed as mean  5:  SD (n  =  4). 
* P  <  0.0001  compared with control incubation (Peritz' F  test). 
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the Amount of yon Willebrand Factor and Fibronectin in the 
Endothelial Cell Extracellular Matrix 
Addition  Incubation  yon Willebrand 
to cells  of matrix  factor  Fibronectin 
ng/lO  6 cells  ltg/lO  6 cells 
-  --  88  5:17  11.5  5:2.2 
--  von Willebrand Factor  60  +  23  NT 
PMA  -  13  5:  10"  1.4  5:  0.7* 
PMA  von Willebrand factor  56  5:5  NT 
Thrombin  -  24  5:  6*  NT 
Endothelial cells were grown for 3 d in the presence of PMA (20 ng/ml). After 
removing the cells, the matrices were incubated for 1 h with Michaelis buffer 
with 1% BSA or Michaelis buffer with 1% BSA and 10 ~tg/ml von Willebrand 
factor.  Then  the  matrices were  scraped off the  flasks.  The  amounts of von 
Willebrand factor and fibronectin were determined as described.  Results are 
expressed as mean  +  SD (n  =  3). 
* P  <  0.001  (Peritz' F  test). 
NT,  not tested. 
tents of fibronectin and von Willebrand factor were also seen 
when  [35S]methionine-labeled  proteins  from  extracellular 
matrix extracts were immunoprecipitated with monoclonal 
antibodies  against  fibronectin  and  von  Willebrand  factor 
(Fig. 4).  Antifibronectin antibodies precipitated a 220,000- 
mol-wt protein that co-migrated with purified plasma fibro- 
nectin  (not shown).  Anti-von Willebrand factor antibodies 
precipitated a 225,000-mol-wt protein that co-migrated with 
purified plasma von Willebrand factor. A 55,000-mol-wt pro- 
tein and two proteins of 45,000 and 47,000 mol wt were pre- 
cipitated with both antibodies.  These impurities were also 
found in control precipitations (not shown). The decrease in 
von Willebrand factor and fibronectin contents was accompa- 
nied by a decrease in the ability of the isolated extracellular 
matrix to support platelet adhesion when these matrices were 
perfused with platelets resuspended in HAS (Fig. 5). The ad- 
dition of normal plasma to the perfusate or the addition of 
purified  von  Willebrand  factor to  the  HAS  overcame the 
PMA-induced inability to support platelet adherence to the 
matrix (Fig. 5, Table VI). Addition of purified plasma fibro- 
nectin had no influence on the number of platelets adhering 
to a  PMA-treated matrix.  Addition  of purified von Wille- 
Figure 4. Influence of a 3-d cul- 
ture in the presence of PMA on 
extracellular  von  Willebrand 
factor  and  fibronectin.  Endo- 
thelial cells were maintained in 
serum-free  medium  with  0.2 
MBq/ml  [35S]methionine  for 
48 h with or without  10 ng/ml 
PMA.  Extracellular  matrices 
were  isolated  and  fibronectin 
and von Willebrand factor were 
immunoprecipitated  and  sepa- 
rated  by SDS  PAGE. Proteins 
were visualized by autoradiog- 
raphy as described in Materials 
and  Methods.  Lanes 1 and 2, 
antifibronectin immunoprecipi- 
tate;  lanes  3  and  4,  anti-von 
WiUebrand factor  iinmunopre- 
cipitate; lanes 1 and 3, cells in- 
cubated 48 h with PMA; lanes 
2 and 4, control cells. 
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Figure 5.  Time course of platelet deposition on extracellular  ma- 
trices produced by endothelial cells (solid circle) and PMA-treated 
endothelial  cells (open circle). Endothelial cells were treated for 
3 d with 20 ng/ml PMA. After isolation of the matrix,  the matrix 
was perfused  with platelets resuspended  in plasma or HAS. The 
amount  of surface  covered  with  platelets  was determined  mor- 
phometrically.  Results are means of two determinations. 
I 
brand factor dissolved in HAS to matrices of PMA-treated 
cells increased the amount of von Willebrand factor in this 
matrix (Table V). 
Besides PMA, thrombin treatment of endothelial cells also 
resulted in a strong decrease in the ability to support platelet 
adhesion (Table VI). This decrease could be abolished by the 
addition of von Willebrand factor to the perfusate, but not by 
the addition of purified plasma fibronectin. 
Discussion 
The extracellular matrix of cultured endothelial cells may be 
used as a model for subendothelium in studies of  blood plate- 
let-vessel wall interactions (1, 2, 33, 34, 40). We have previ- 
ously reported on the interaction of platelets with the endo- 
thelial  cell  and  their  extracellular  matrix  in  a  perfusion 
chamber under  well-defined  flow  conditions  (33)  and  we 
have shown that the presence of von Willebrand factor and 
fibronectin in the extracellular matrix is an absolute require- 
ment for normal platelet adhesion (10). Both von Willebrand 
factor and  fibronectin are synthesized by endothelial  cells 
Table VI. Effect of (Purified)  von Willebrand Factor and 
Fibronectin on Platelet Adhesion on Matrices of 
PMA-treated Cells 
Platelet coverage on matrix of 
Control ceils  PMA-treated cells Thrombin-treated cells 
Perfusate  percent coverage  percent coverage  percent coverage 
HAS  26.7  5:0.5  8.5  5:5.3  9.1  5:4.8 
HAS  +  VWF  26.3  5:3.1  22.0  5:3.3  29.4  5:1.4 
HAS  +  FN  21.8  -I-  1.7  10.8  ___  0.7  7.8  +  4.0 
Plasma  30.9  5:2.5  22.2  +  3.5  ND 
Endothelial cells were grown for 4  d  in the presence or absence of PMA (20 
ng/ml) or thrombin (1 U/ml). The matrices were isolated and exposed to plate- 
lets resuspended in HAS,  HAS supplemented with 10 p.g/ml von Willebrand 
factor, HAS supplemented with 200 ~tg/ml fibronectin, or platelets resuspend- 
ed in plasma. After perfusions, the matrices were fixed and stained, and the 
percentage  surface  coverage  was  determined  by  morphological evaluation. 
Results are expressed as mean  +  SD (n  =  4). 
ND,  not done. 
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(9, 38). However, these major endothelial cell proteins are 
not localized in the same subcellular compartments, and, in 
spite of  their co-distribution outside the cell, divergent routes 
of intracellular translocation of fibronectin and von Wille- 
brand factor have been suggested (9, 25,  38). 
We have studied the  influence of perturbation of endo- 
thelial cells on the amounts of fibronectin and von Wille- 
brand  factor in  their  extracellular matrix  and  the  conse- 
quences of a  changed composition of the matrix on their 
ability to support platelet adhesion.  Platelet adhesion was 
evaluated by measuring the percentage coverage of the extra- 
cellular matrix with platelets. The percentage coverage cor- 
relates well with the number of platelets adhering to the ma- 
trix (33). A coverage of 10% means ~106 platelet/cm  2 (33). 
In the experiments described in this paper, treatment of en- 
dothelial cells with PMA or thrombin does not influence the 
spreading of the platelets on the matrix (data not shown), in- 
dicating  that  the  same  correlation between  coverage and 
platelet number exists. 
A  3-d culture of endothelial cells in the presence of the 
phorbol ester PMA (20 ng/ml) caused an 80% decrease in 
the von Willebrand factor contents of the endothelial cell ex- 
tracellular matrix (Table V and Fig. 4). Comparable results 
were found with thrombin. This decrease in amount of von 
Willebrand factor coincided with a decrease in the number 
of platelets adhering to the matrix (Table VI and Fig.  5). 
The decrease in platelet adhesion to matrices of PMA- 
treated endothelial ceils was corrected when perfusions were 
performed with platelets resuspended in plasma or in the 
human albumin solution with the addition of purified von 
Willebrand factor. Addition of von Willebrand factor to avon 
WiUebrand factor-depleted matrix increased the amount of 
von Willebrand factor in these matrices. Addition of plasma 
fibronectin to the perfusate had no influence on the number 
ofplatelets adhering to the matrix. These results indicate that 
upon perturbation with PMA or thrombin, endothelial cells 
alter the composition of their matrix, and that this alteration 
has consequences for the adhesion of platelets to this matrix. 
Evidently, the extracellular matrix of  endothelial cells is sub- 
jected to a continuous process of construction and degrada- 
tion. After PMA treatment, presumably by the induction of 
proteases (26), endothelial ceils demolish their matrix more 
rapidly (16) and thus favor decreased deposition of not only 
structural extracellular matrix proteins, but also proteins, 
like von Willebrand factor, that are involved in platelet adhe- 
sion. PMA induces plasminogen activator secretion by en- 
dothelial cells (18). Guisasola et al. have showed that plasmin 
could destroy von WiUebrand factor (8). The decrease in the 
amount of von Willebrand factor of the extracellular matrix 
might be due to the action of the induced plasmin activity. 
Prolonged incubation of endothelial cells with PMA results 
in an increased secretion of von Willebrand factor to the cul- 
ture medium (25). Probably, in the presence of PMA, newly 
synthesized von Willebrand factor is predominantly secreted 
towards the culture medium and is no longer incorporated 
into the extracellular matrix. 
In immunoprecipitation studies with monoclonal antibod- 
ies  against  von  Willebrand  factor  and  fibronectin  from 
[35S]methionine-labeled matrices we always found a strong 
55-kD band and two weak bands of  45 and 47 kD. The nature 
of these  bands  is  unknown,  but  they  are  also  strongly 
influenced by PMA treatment. Evidently PMA changes the 
complete composition of the matrix,  not only von Wille- 
brand factor and fibronectin. 
Treatment of endothelial cells for 2  h with thrombin or 
PMA had no influence on the total amounts of von Wille- 
brand factor and fibronectin in the endothelial cell matrix. 
However, there was an increased ability of the matrix to sup- 
port platelet adhesion. This increase was very distinct when 
the matrix was perfused in the absence of von WiUebrand 
factor and fibronectin in the perfusate. Preincubation of the 
matrix of thrombin-treated cells with  a  monoclonal anti- 
body  against  von  Willebrand  factor completely inhibited 
platelet adhesion to these matrices (Table II). Probably not 
only the total amounts of von Willebrand factor and fibronec- 
tin present in the matrix determine the number of platelets 
adhering, but also the way these proteins are organized in the 
matrix. Only relatively few von Willebrand factor molecules 
are present at sites in the subendothelium where they are 
reactive to platelets (37).  Most other molecules are present 
at irrelevant sites,  out of reach of passing platelets. Another 
possibility is that the multimeric composition of von Wille- 
brand factor in the matrix has been changed, as a result of 
the perturbation.  In all probability the support of platelet 
adhesion is best performed by multimers of high molecular 
mass.  Perhaps  the brief perturbation caused  by PMA  or 
thrombin  results  in  an  increase  in  multimers  with  high 
molecular mass. Our speculation is that thrombin treatment 
of endothelial cells results in a fast reorganization of their 
matrix, resulting in an enhanced amount of reactive von Wil- 
lebrand factor or fibronectin. 
Recently we have shown that treatment of endothelial cells 
with  thrombin results  in  an  instantaneous  increase in the 
amount  of von Willebrand  factor secreted  to  the  culture 
medium, and that this increased secretion depends on the 
methylation of phosphatidylethanolamine (3).  Addition of 
3-deazaadenosine, an inhibitor of the enzymic methylation 
of phosphatidylethanolamine, not only inhibited the release 
of von Willebrand factor into the culture medium (3), but 
also prevented an increase in the amount of  platelets adhering 
to the matrix (Table II). Also, the increased secretion to the 
culture medium after thrombin treatment (17) and the in- 
crease in platelet adhesion could not be inhibited by cyclo- 
heximide, an inhibitor of protein synthesis.  This  suggests 
that the proposed alteration of the matrix organization is 
caused by the same cellular mechanism that releases recep- 
tor-mediated von Willebrand  factor from cellular  storage 
sites to the culture medium (3). On the other hand, addition 
of purified von Willebrand factor to the culture medium of 
the cells in a concentration at least 10 times higher than nor- 
mally reached in the medium did not increase the reactivity. 
Thus, the increased reactivity of the matrix was not due to 
increased secretion of von Willebrand factor into the culture 
medium after perturbation followed by increased binding to 
the matrix. 
The increased reactivity of  the matrix after 2 h of  thrombin 
treatment depends on the presence of cells during these 2 h. 
In the absence of cells, thrombin did not affect the ability 
of the matrix to support platelet adhesion (Fig. 2).  More- 
over, a 2-h incubation of the cells with the Ca2÷-ionophore 
A23187 or PMA also induced the increased reactivity of the 
The Journal of Cell Biology, Volume  104, 1987  702 matrix (Table III). Thus, the increased reactivity is not likely 
to be due to a direct proteolytic effect of thrombin on matrix 
proteins. 
The presence of von Willebrand factor and fibronectin in 
the endothelial cell matrix is required  for normal platelet 
adhesion (10). However, this does not mean that they are the 
only matrix proteins involved in platelet adhesion. A co-dis- 
tribution of von Willebrand factor in the extracellular matrix 
of endothelial cells with fibronectin and collagen types IV 
and V has been shown (42). ELISA studies showed an inter- 
action of thrombospondin with collagen type V, von Wille- 
brand factor, and fibronectin (23), and recently the participa- 
tion of laminin and  nidogen in platelet adhesion has been 
indicated  (4,  11). It is possible that thrombin changes  the 
amounts of other matrix proteins such as collagen types IV 
and  V,  laminin,  or  nidogen,  and  that  these  changes  are 
responsible for the increased ability of the matrix to support 
platelet adhesion.  Further  studies are necessary  to answer 
these questions. 
Perturbation  of endothelial cells with PMA induces a se- 
ries of metabolic changes, resulting in an altered  participa- 
tion of endothelial cells in hemostatic processes.  PMA in- 
duces the synthesis of tissue factor by endothelial cells (19), 
and enhances prostacyclin  synthesis (24) and the secretion of 
yon Willebrand factor and tissue-type plasminogen activator 
(17, 18). Here we show that long-term incubation of endo- 
thelial cells with PMA, a condition that may be relevant for 
endothelial cells in pathophysiological situations, resulted in 
decreased amounts of von Willebrand factor and fibronectin 
in their extracellular matrix, which had direct consequences 
for platelet adhesion.  From these in vitro results, it seems 
likely  that  endothelial  cells  respond  to  perturbation  by, 
among other things,  increasing their prostacyclin  synthesis 
and by decreasing the reactivity of their matrix, making it 
more difficult for platelets to adhere and aggregate on the dis- 
turbed surface of the vessel wall. This may be another good 
example of the potential of endothelial cells to control physi- 
ological processes such as hemostasis. 
The findings described in this paper show that the endo- 
thelial cell matrix is not an inert protein layer, but that the 
composition and organization of the proteins in the matrix 
are closely regulated  by the cells on top. After 3 d of PMA- 
treatment,  80 % of the von Willebrand  factor and fibronectin 
disappear,  suggesting that these proteins are removed by an 
active process. Also, 2 h of thrombin  treatment changes the 
reactivity of the matrix, suggesting that an active process re- 
organizes the already  formed matrix. Perturbation  of endo- 
thelial cells strongly influences their metabolism, resulting 
in a changed spectrum of secreted proteins and in the altera- 
tion of the insoluble matrix underneath  the cells. 
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